Prenatal NAP+SAL Prevents Developmental Delay in Down Syndrome through affects on NMDA and GABA receptors

OBJECTIVE: Down Syndrome affects 1/800 infants. Prenatal NAP+SAL prevents developmental delay in Ts65Dn mice. We investigated if this finding involves NMDA and GABA receptor subunits. STUDY DESIGN: Pregnant Ts65Dn mice were treated with placebo or NAP+SAL on gestational days 8-12. After developmenta...

Full description

Saved in:
Bibliographic Details
Published in:Am J Obstet Gynecol
Main Authors: VINK, Joy, INCERTI, Maddelena, TOSO, Laura, ROBERSON, Robin, ABEBE, Daniel, SPONG, Catherine Y.
Format: Artigo
Language:Inglês
Published: 2009
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6503529/
https://ncbi.nlm.nih.gov/pubmed/19327737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2009.01.052
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items